Larson Financial Group’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-43
Closed -$2K 580
2019
Q1
$2K Hold
43
﹤0.01% 396
2018
Q4
$1K Buy
+43
New +$1K ﹤0.01% 452